Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$49M 79.7%Beat EPS +105.8%
Total revenue, Q2 '25 (USD).

Did Zymeworks Beat Earnings?

Zymeworks (ZYME) reported Q2 '25 revenue of $49M, up 153.2% year-over-year, with reported EPS of $0.03. That topped the $-0.52 analyst estimate by 105.8% — an earnings beat.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Zymeworks’s job postings, web traffic, and employee business outlook. See the full ZYME stock analysis or the earnings calendar for upcoming reports.

Zymeworks Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue16M31M27M49M28M2.5M2.4M4.6M
Gross margin100.0%100.0%100.0%100.0%100.0%32.8%-18.2%100.0%
Operating margin-213.8%-71.6%-94.5%-1.4%-80.1%-1,755.5%-1,956.7%-919.0%
Net income-30M-24M-23M2.3M-20M-41M-44M-45M
Net margin-186.6%-75.8%-83.5%4.8%-71.0%-1,638.5%-1,834.0%-980.8%
EPS———$0.03————

Zymeworks Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Zymeworks’s quarterly revenue moved from $16M to $4.6M. Net margin compressed from -186.6% to -980.8%, against a 100% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Zymeworks has beaten Wall Street EPS estimates in 1 of its last 1 reported quarters.

When Is Zymeworks’s Next Earnings Date?

Zymeworks reports earnings on a quarterly schedule. Its most recent report covered Q2 '25. For the confirmed upcoming date — and every other company reporting soon — see the ZYME earnings calendar.

Frequently Asked Questions: Zymeworks Earnings

Zymeworks's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Zymeworks reported Q2 '25 EPS of $0.03 on revenue of $49M (+153.2% YoY). Zymeworks beat estimates, reporting $0.03 vs. the $-0.52 estimate.

Zymeworks reported Q2 '25 revenue of $49M, up 153.2% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ZYME AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.